Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Istvan Toth

Showing results (321-330 of 335) with videos related to

Pageof 34
Sort By:
Nanomedicine (London, England)|April 25, 2013
Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccineAbdullah A H Ahmad Fuaad, Zhongfan Jia, Mehfuz Zaman, et al.
Mbio|December 2, 2020
Erratum for Rivera-Hernandez et al., "An Experimental Group A <i>Streptococcus</i> Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model"Tania Rivera-Hernandez, Diane G Carnathan, Scott Jones, et al.
Pharmaceutics|April 23, 2022
Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant SystemsAhmed O Shalash, Armira Azuar, Harrison Y R Madge, et al.
Bioorganic & Medicinal Chemistry|October 15, 2010
Pro-apoptotic activity of lipidic α-amino acids isolated from Protopalythoa variabilisDiego Veras Wilke, Paula Christine Jimenez, Renata Mendonça Araújo, et al.
Cell Host & Microbe|May 14, 2021
Pre-clinical evaluation of a whole-parasite vaccine to control human babesiosisHanan A Al-Nazal, Emily Cooper, Mei Fong Ho, et al.
Vaccines|August 26, 2022
Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A StreptococcusArmira Azuar, Harrison Y R Madge, Jennifer C Boer, et al.
ACS Infectious Diseases|July 25, 2023
Activity Relationship of Poly(ethylenimine)-Based Liposomes as Group A <i>Streptococcus</i> Vaccine Delivery SystemsShengbin Jin, Jiahui Zhang, Ummey J Nahar, et al.
Mbio|June 16, 2016
Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease ModelsTania Rivera-Hernandez, Manisha Pandey, Anna Henningham, et al.
NPJ Vaccines|January 14, 2025
A synthetic cyclic peptide for promoting antigen presentation and immune activationJiahui Zhang, Harrison Y R Madge, Asmaa Mahmoud, et al.
Pharmaceutics|February 25, 2023
Liposomal Formulations of a Polyleucine-Antigen Conjugate as Therapeutic Vaccines against Cervical CancerFarrhana Z Firdaus, Stacey Bartlett, Waleed M Hussein, et al.
Pageof 34

Showing results (321-330 of 335) with videos related to

Sort By:
Pageof 34
Nanomedicine (London, England)|April 25, 2013
Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccineAbdullah A H Ahmad Fuaad, Zhongfan Jia, Mehfuz Zaman, et al.
Mbio|December 2, 2020
Erratum for Rivera-Hernandez et al., "An Experimental Group A <i>Streptococcus</i> Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model"Tania Rivera-Hernandez, Diane G Carnathan, Scott Jones, et al.
Pharmaceutics|April 23, 2022
Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant SystemsAhmed O Shalash, Armira Azuar, Harrison Y R Madge, et al.
Bioorganic & Medicinal Chemistry|October 15, 2010
Pro-apoptotic activity of lipidic α-amino acids isolated from Protopalythoa variabilisDiego Veras Wilke, Paula Christine Jimenez, Renata Mendonça Araújo, et al.
Cell Host & Microbe|May 14, 2021
Pre-clinical evaluation of a whole-parasite vaccine to control human babesiosisHanan A Al-Nazal, Emily Cooper, Mei Fong Ho, et al.
Vaccines|August 26, 2022
Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A StreptococcusArmira Azuar, Harrison Y R Madge, Jennifer C Boer, et al.
ACS Infectious Diseases|July 25, 2023
Activity Relationship of Poly(ethylenimine)-Based Liposomes as Group A <i>Streptococcus</i> Vaccine Delivery SystemsShengbin Jin, Jiahui Zhang, Ummey J Nahar, et al.
Mbio|June 16, 2016
Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease ModelsTania Rivera-Hernandez, Manisha Pandey, Anna Henningham, et al.
NPJ Vaccines|January 14, 2025
A synthetic cyclic peptide for promoting antigen presentation and immune activationJiahui Zhang, Harrison Y R Madge, Asmaa Mahmoud, et al.
Pharmaceutics|February 25, 2023
Liposomal Formulations of a Polyleucine-Antigen Conjugate as Therapeutic Vaccines against Cervical CancerFarrhana Z Firdaus, Stacey Bartlett, Waleed M Hussein, et al.
Pageof 34